BFO
CVKD icon

Biltmore Family Office’s Cadrenal Therapeutics CVKD Stock Holding History

Biltmore Family Office’s Portfolio CVKD Stock Details CVKD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-733
Closed -$5.17K – 273
2024
Q2 		$5.17K Hold
733
– – ﹤0.01% 236
2024
Q1 		$6.71K Hold
733
– – ﹤0.01% 224
2023
Q4 		$8.14K Hold
733
– – ﹤0.01% 221
2023
Q3 		$7.48K Buy
+733
New +$7.48K ﹤0.01% 229